Vaccine research; testing diphtheria vaccine

Vaccine research; testing diphtheria vaccine

G255/0084 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 27.3MB

Downloadable file size: 1.6MB

Price image Pricing

Please login to use the price calculator


Caption: Diphtheria vaccine. Researcher pipettes pink liquid into phials during testing of a diphtheria vaccine. Corynebacterium diphtheriae, the bacterium which causes diphtheria, produces a toxin which kills muscle cells and causes life- threatening symptoms such as paralysis and heart failure. This toxin can be chemically modified by formalin treatment so that it retains its ability to generate an immune response, but loses its toxicity. Vaccination with the toxoid (modified toxin) sensitises the immune system to the toxin, so that susequent infection is met with an intense antibody response which neutralises the toxin.

Release details: Model release not required. Property release not required.

Keywords: bioengineered, bioengineering, biotechnology, diphtheria, diphtheria vaccine, drug, drugs, genetic, genetics, manufacture, production, research, toxoid, vaccine

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.